Skip to main content
SpringerLink
Log in

The combination of slow-release nifedipine and atenolol for stable angina

  • Nifedipine, Cardioprotection, and Ischemic Heart Disease
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Beta-adrenoceptor antagonists, such as atenolol and the dihydropyridine calcium antagonist nifedipine, have antianginal actions that should prove complementary when the drugs are used in combination. Atenolol acts primarily by reducing myocardial oxygen demand, while the vasodilator effects of nifedipine can both reduce demand and increase oxygen supply. The slow-release tablet formulation of nifedipine (Nifedipine Retard) provides more persistent plasma concentrations than the conventional capsule formulation, which may prolong the duration of action. There is increasing evidence that the plasma nifedipine concentration is closely related to efficacy, although the absolute concentration required to improve exercise tolerance in patients with angina varies between individuals. Clinical studies indicate that for many patients the duration of action of slow-release nifedipine, particularly when added to atenolol, is less than 12 hours. This reflects the extensive but variable first-pass metabolism of nifedipine, leading to subtherapeutic trough concentrations. To achieve 24-hour symptom relief, slow-release nifedipine will often need to be given three times daily to patients with angina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Challenor VF, Waller DG, George CF. Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.Cardiovasc Drugs Ther 1989;3:275–285.

    Article  PubMed  Google Scholar 

  2. Hamer J. Beta-adrenergic blocking drugs. In: Hamer J, ed.Drugs for heart disease. London: Chapman and Hall, 1979:148–243.

    Google Scholar 

  3. Gaglione A, Hess OM, Corin WJ, et al. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease?J Am Coll Cardiol 1987;10:299–310.

    Article  PubMed  CAS  Google Scholar 

  4. Matsuzaki M, Patritti J, Tajimi T, et al. Effects of beta-blockade on regional myocardial flow and function during exercise.Am J Physiol 1984;247:H52-H60.

    PubMed  CAS  Google Scholar 

  5. Fleckenstein A, Tritthart H, Doring HJ, Byon KS. BAY a 1040 — ein hochaktiver Ca2+ antagonistischer Inhibitor der elektro-mechanischen Koppelungsprozesse im Warmbluter-Myokard.Arzneim-Forsch 1972;22:22–33.

    CAS  Google Scholar 

  6. Sherman LG, Liang C-S. Nifedipine in chronic stable angina: A double-blind placebo-controlled cross-over trial.Am J Cardiol 1983;51:706–711.

    PubMed  CAS  Google Scholar 

  7. Braun S, Terdiman R, Berenfield D, Laniado S. Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris.Am Heart J 1985;3:478–485.

    Article  Google Scholar 

  8. Bassan M, Weiler-Ravell D, Shalev O. The additive antianginal action of oral nifedipine in patients receiving propranolol: Magnitude and duration of effect.Circulation 1982;66:710–716.

    PubMed  CAS  Google Scholar 

  9. Findlay IN, MacLeod K, Ford M, Gillen G, Elliott AT, Dargie HJ. Treatment of angina pectoris with nifedipine and atenolol: Efficacy and effect on cardiac function.Br Heart J 1986;55:240–245.

    PubMed  CAS  Google Scholar 

  10. Lynch P, Dargie H, Krikler S, Krikler D. Objective assessment of antianginal treatment: A double-blind comparison of propranolol, nifedipine, and their combination.Br Med J 1980;281:184–187.

    PubMed  CAS  Google Scholar 

  11. Kenmure AC, Scruton JH. A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol.Br J Clin Pract 1979;33:49–51.

    PubMed  CAS  Google Scholar 

  12. Tweddel AC, Beattie JM, Murray RG, Hutton I. The combination of nifedipine and propranolol in the management of patients with angina pectoris.Br J Clin Pharmacol 1981;12:229–233.

    PubMed  CAS  Google Scholar 

  13. Keyriläinen O, Bae E, Rytkonen U, et al. Metoprolol, nifedipine, and the combination in effort angina pectoris. I Clinical effects (abstract No. 1464).Eur Heart J 1984;5(Suppl 1):293.

    Google Scholar 

  14. Uusitalo A, Arstila M, Bae EA, et al. Metoprolol, nifedipine, and the combination in stable effort angina pectoris.Am J Cardiol 1986;57:733–737.

    Article  PubMed  CAS  Google Scholar 

  15. Waller DG, Renwick AG, Gruchy BS, George CF. The first pass metabolism of nifedipine in man.Br J Clin Pharmacol 1984;18:951–954.

    PubMed  CAS  Google Scholar 

  16. Challenor VF, Waller DG, Gruchy BS, et al. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.Br J Clin Pharmacol 1986;22:565–570.

    PubMed  CAS  Google Scholar 

  17. Chaitman BR, Wagwiart P, Pasternac A, et al. Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris. Comparison at 1, 3 and 8 hours and correlation with plasma drug concentration.Am J Cardiol 1984;53:1–9.

    Article  PubMed  CAS  Google Scholar 

  18. Adamo L, Novo S, Bucca V, Strano A. Effects of calcium entry blockers and of beta-blockers on exercise tolerance in patients of different age suffering from angina pectoris.Eur Heart J 1985:6(Suppl 1):80.

    Google Scholar 

  19. Crake T, Quyyumi AA, Wright C, et al. Treatment of angina pectoris with nifedipine: Double-blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.Br Heart J 1987;58:617–620.

    PubMed  CAS  Google Scholar 

  20. Woodward SA, Allen S, Boyle R, et al. A comparison of the effect of carvedilol and nifedipine on the exercise capacity of patients with ischaemic heart disease.Br J Clin Pharmacol 1988;25:658p.

    Google Scholar 

  21. Akhras F, Chambers J, Jackson G. A randomised doubleblind cross-over study of isosorbide mononitrate and Nifedipine Retard in stable, angina.Cardiovasc Drugs Ther 1987;1:210.

    Google Scholar 

  22. Brugmann U, Blasini R, Rudolph W. Anti-ischaemic effect of nifedipine in long-acting form: Results of a randomised, double-blind, placebo-controlled acute cross-over study.Herz 1983;8:206–210.

    PubMed  CAS  Google Scholar 

  23. Gibelli G, Carnovali M, Orvieni C, et al. Effect and duration of action of nifedipine 20 mg tablets: double-blind ergometric evaluation versus placebo.Curr Ther Res 1983;33:295–304.

    Google Scholar 

  24. Arnim, T von, Erath A. Nitrates and calcium antagonists for silent myocardial ischaemia.Am J Cardiol 1988;61:15E-18E.

    PubMed  Google Scholar 

  25. Stern Z, Zylber-Katz E, Levy M. Nifedipine plasma concentration in patients treated for angina pectoris.Int J Clin Pharmacol Ther Toxicol 1984;22:198–203.

    PubMed  CAS  Google Scholar 

  26. Mason WD, Winer N, Kochak G, et al. Kinetics and absolute bioavailability of atenolol.Clin Pharmacol Ther 1979;25:408–415.

    PubMed  CAS  Google Scholar 

  27. Schwartz JB. Atenolol in the treatment of angina. Once daily cardioselective beta-blockade for angina pectoris.Drugs 1983;25(Suppl 2):160–165.

    Article  Google Scholar 

  28. Sandberg M, Foale RA. Atenolol with and without nifedipine in the treatment of angina pectoris.Drugs 1988;35 (Suppl 4):51–55.

    PubMed  Google Scholar 

  29. Foale RA. A comparison of atenolol (Tenormin LS) 50 mg and the fixed combination of atenolol 50 mg and nifedipine 20 mg (Tenif) in patients with stable angina pectoris (abstract). 4th International Symposium on Calcium Antagonists. Florence, 1989:159.

  30. Banim SO, Maltz MB, Rich J. A comparison of atenolol (Tenormin LS) 50 mg, nifedipine (Adalat SR) 20 mg and their combination (Tenif) with treatment of chronic stable angina pectoris (Abstract). 4th International Symposium on Calcium Antagonists. Florence, 1989:149.

  31. Boden WE, Korr KS, Bough EW. Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.JAMA 1985;253:1131–1135.

    Article  PubMed  CAS  Google Scholar 

  32. Jenkins RM, Nagle RE. The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris.Postgrad Med J 1982;58:697–700.

    Article  PubMed  CAS  Google Scholar 

  33. Findlay IN, Dargie HJ. The effects of nifedipine, atenolol and that combination on left ventricular function.Postgrad Med J 1983;59(Suppl 2):70–3.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Group, Centre Block, Southampton General Hospital, Tremona Road, SO9 4XY, Southampton, UK

    Derek G. Waller & Vivian F. Challenor

Authors
  1. Derek G. Waller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivian F. Challenor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waller, D.G., Challenor, V.F. The combination of slow-release nifedipine and atenolol for stable angina. Cardiovasc Drug Ther 4 (Suppl 5), 899–904 (1990). https://doi.org/10.1007/BF02018289

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018289

Key Words

Search

Navigation